Terms: = Prostate cancer AND IDH2, P48735, 3418, ENSG00000182054, IDHM, mNADP-IDH, IDH, IDP, ICD-M
30 results:
1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
2. Genomic characterization of idh-mutant astrocytoma progression to grade 4 in the treatment setting.
Rautajoki KJ; Jaatinen S; Hartewig A; Tiihonen AM; Annala M; Salonen I; Valkonen M; Simola V; Vuorinen EM; Kivinen A; Rauhala MJ; Nurminen R; Maass KK; Lahtela SL; Jukkola A; Yli-Harja O; Helén P; Pajtler KW; Ruusuvuori P; Haapasalo J; Zhang W; Haapasalo H; Nykter M
Acta Neuropathol Commun; 2023 Nov; 11(1):176. PubMed ID: 37932833
[TBL] [Abstract] [Full Text] [Related]
3. 68 Ga-PSMA-11 PET/CT Imaging in Brain Gliomas and Its Correlation With Clinicopathological Prognostic Parameters.
Verma P; Singh BK; Sudhan MD; Singh RK; Bagul SD; Chandak AR; Soni BK; Shelly D; Basu S
Clin Nucl Med; 2023 Dec; 48(12):e559-e563. PubMed ID: 37883060
[TBL] [Abstract] [Full Text] [Related]
4. Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic-mitochondrial tricarboxylic acid cycle that can be targeted for therapeutic purposes in prostate cancer.
Gonthier K; Weidmann C; Berthiaume L; Jobin C; Lacouture A; Lafront C; Harvey M; Neveu B; Loehr J; Bergeron A; Fradet Y; Lacombe L; Riopel J; Latulippe É; Atallah C; Shum M; Lambert JP; Pouliot F; Pelletier M; Audet-Walsh É
Mol Oncol; 2023 Oct; 17(10):2109-2125. PubMed ID: 37086156
[TBL] [Abstract] [Full Text] [Related]
5. Occurrence of non-central nervous system cancers during postoperative follow-up of patients who underwent surgery for a WHO grade II glioma: implications for therapeutic management.
Duffau H
J Neurooncol; 2023 Mar; 162(1):237-244. PubMed ID: 36913047
[TBL] [Abstract] [Full Text] [Related]
6. PTPRD and CNTNAP2 as markers of tumor aggressiveness in oligodendrogliomas.
Rautajoki KJ; Jaatinen S; Tiihonen AM; Annala M; Vuorinen EM; Kivinen A; Rauhala MJ; Maass KK; Pajtler KW; Yli-Harja O; Helén P; Haapasalo J; Haapasalo H; Zhang W; Nykter M
Sci Rep; 2022 Aug; 12(1):14083. PubMed ID: 35982066
[TBL] [Abstract] [Full Text] [Related]
7. Marsdenia tenacissima (Roxb.) Moon injection exerts a potential anti-tumor effect in prostate cancer through inhibiting ErbB2-GSK3β-HIF1α signaling axis.
Chen X; Luo Z; Liu X; Li X; Li Q; Zhang W; Liu Y; Cheng Z; Yang X; Liu Y; Jin R; Zhu D; Wang F; Lu Q; Su Z; Guo H
J Ethnopharmacol; 2022 Sep; 295():115381. PubMed ID: 35595220
[TBL] [Abstract] [Full Text] [Related]
8. Structural Analysis of the cl-Par-4 Tumor Suppressor as a Function of Ionic Environment.
Raut KK; Ponniah K; Pascal SM
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33807852
[TBL] [Abstract] [Full Text] [Related]
9. Bayesian Individual Dynamic Predictions with Uncertainty of Longitudinal Biomarkers and Risks of Survival Events in a Joint Modelling Framework: a Comparison Between Stan, Monolix, and NONMEM.
Riglet F; Mentre F; Veyrat-Follet C; Bertrand J
AAPS J; 2020 Feb; 22(2):50. PubMed ID: 32076894
[TBL] [Abstract] [Full Text] [Related]
10. idh2 reprograms mitochondrial dynamics in cancer through a HIF-1α
Wang Y; Agarwal E; Bertolini I; Ghosh JC; Seo JH; Altieri DC
FASEB J; 2019 Dec; 33(12):13398-13411. PubMed ID: 31530011
[TBL] [Abstract] [Full Text] [Related]
11. Intrinsically disordered proteins and phenotypic switching: Implications in cancer.
Kulkarni V; Kulkarni P
Prog Mol Biol Transl Sci; 2019; 166():63-84. PubMed ID: 31521237
[TBL] [Abstract] [Full Text] [Related]
12. The cancer driver genes idh1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
13. SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG-rearranged prostate cancer.
Hernández-Llodrà S; Segalés L; Safont A; Juanpere N; Lorenzo M; Fumadó L; Rodríguez-Vida A; Cecchini L; Bellmunt J; Lloreta-Trull J
Prostate; 2019 Jul; 79(10):1156-1165. PubMed ID: 31090082
[TBL] [Abstract] [Full Text] [Related]
14. Reprogramming of Isocitrate Dehydrogenases Expression and Activity by the Androgen Receptor in prostate cancer.
Gonthier K; Poluri RTK; Weidmann C; Tadros M; Audet-Walsh É
Mol Cancer Res; 2019 Aug; 17(8):1699-1709. PubMed ID: 31068457
[TBL] [Abstract] [Full Text] [Related]
15. The contribution of the rs55705857 G allele to familial cancer risk as estimated in the Utah population database.
Hummel S; Kohlmann W; Kollmeyer TM; Jenkins R; Sonnen J; Palmer CA; Colman H; Abbott D; Cannon-Albright L; Cohen AL
BMC Cancer; 2019 Mar; 19(1):190. PubMed ID: 30823903
[TBL] [Abstract] [Full Text] [Related]
16. Structural and Dynamical Order of a Disordered Protein: Molecular Insights into Conformational Switching of PAGE4 at the Systems Level.
Lin X; Kulkarni P; Bocci F; Schafer NP; Roy S; Tsai MY; He Y; Chen Y; Rajagopalan K; Mooney SM; Zeng Y; Weninger K; Grishaev A; Onuchic JN; Levine H; Wolynes PG; Salgia R; Rangarajan G; Uversky V; Orban J; Jolly MK
Biomolecules; 2019 Feb; 9(2):. PubMed ID: 30813315
[TBL] [Abstract] [Full Text] [Related]
17. pH-Induced Folding of the Caspase-Cleaved Par-4 Tumor Suppressor: Evidence of Structure Outside of the Coiled Coil Domain.
Clark AM; Ponniah K; Warden MS; Raitt EM; Yawn AC; Pascal SM
Biomolecules; 2018 Dec; 8(4):. PubMed ID: 30518159
[TBL] [Abstract] [Full Text] [Related]
18. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia.
Williams P; Basu S; Garcia-Manero G; Hourigan CS; Oetjen KA; Cortes JE; Ravandi F; Jabbour EJ; Al-Hamal Z; Konopleva M; Ning J; Xiao L; Hidalgo Lopez J; Kornblau SM; Andreeff M; Flores W; Bueso-Ramos C; Blando J; Galera P; Calvo KR; Al-Atrash G; Allison JP; Kantarjian HM; Sharma P; Daver NG
Cancer; 2019 May; 125(9):1470-1481. PubMed ID: 30500073
[TBL] [Abstract] [Full Text] [Related]
19. idh1R132H Promotes Malignant Transformation of Benign Prostatic Epithelium by Dysregulating MicroRNAs: Involvement of IGF1R-AKT/STAT3 Signaling Pathway.
Zhang L; Qi M; Feng T; Hu J; Wang L; Li X; Gao W; Liu H; Jiao M; Wu Z; Bai X; Bie Y; Liu L; Han B
Neoplasia; 2018 Feb; 20(2):207-217. PubMed ID: 29331887
[TBL] [Abstract] [Full Text] [Related]
20. The Genomics of prostate cancer: emerging understanding with technologic advances.
Rubin MA; Demichelis F
Mod Pathol; 2018 Jan; 31(S1):S1-11. PubMed ID: 29297493
[TBL] [Abstract] [Full Text] [Related]
[Next]
